Michael Bragin Email & Phone Number

Philadelphia, PA, US

Princeton, New Jersey, US

Principal forecaster for in-line North American brands with combined sales of over $1 billion, covering therapeutic areas of oncology, neurology & endocrinology/rheumatology, and including short- and long-term planning for two orphan (rare disease) drug assets within these arenas. - Lead forecasting team in execution of forecast model development and.

Newton, MA, US

Led revenue and volume-demand planning processes for both in-line products and pipeline assets. - Delivered tactical and strategic, indication-level forecasts, and set as well as monitored key performance indicators, for a hematology-oncology product generating over $125 million in annual sales. - Collaborated with functional leaders (commercial, clinical.

Brentford, Middlesex, GB

Forecasting and strategic analyses informing global development and commercialization decisions related to GSK’s portfolio of mid- and late-stage hematology-oncology assets. - Global forecast lead for US and EU product launches of a first-in-class multiple myeloma therapy, including collaboration with global market research lead in the deployment of a.

Tel-Aviv, IL

Served in various roles as commercial assessment principal for external BD&L targets, as forecasting lead for select internal development-stage assets, and as primary forecaster for select U.S. in-line franchises.- Commercial assessment lead (market research, analytics & forecasting) supporting global in-licensing and acquisition opportunities. Led vendor.

RTP, NC, US

Managed forecasting team and led market assessment and forecast build processes, delivering decision-informing forecasts to commercial executive management, commercial and finance team leaders, senior R&D personnel and BD&L senior management. - Strategic forecasts and project cash flow and valuation-sensitivity analyses for pipeline and BD&L-targeted.

Strategic planning, forecasting, market & business analytics, financial modeling & valuation services, and market & technology assessment supporting franchise development, product portfolio planning, and business development & licensing decisions. Select assignments include: - Managed evaluation of a pharmaceutical company’s proposed acquisition of an.

Boston, Massachusetts, US

Developed and executed product partnering, licensing, and acquisition strategies for life sciences clientele. Notable assignments include: - Led partnering effort for a disposable, acute care medical product in early-stage development. Directed engagement of and led presentations to prospective corporate partners and investors. Developed presentation.

US

Lead internal provider of forecasting, financial modeling and analysis, valuation, market analytics and competitive intelligence driving new product planning and business development & licensing effort. - Sales forecasting, financial modeling, valuation, and transaction structure analysis enabling the $14 million acquisition of patent and trademark rights.

• Led financial modeling and analysis, valuation, and product forecasting efforts for strategic planning, business development & licensing, and product marketing teams.
• Key Achievements: - Led internal financial and valuation analysis driving negotiation and closing of $719 million corporate sale to Genzyme. - Strategic business assessment, including product forecasting, pro forma.

Provided financial modeling, analysis, and valuation facilitating the execution of over $1.4 billion in equity & debt financings, corporate mergers & acquisitions, joint venture arrangements and licensing transactions.

Ms, Biotechnology

Ma, Political Science & Economics

Ba, Political Science

Education record

Accounting, Law & Finance